China NMPA Drug Inspection - Chengdu Hexiangtian Pharmaceutical Co., Ltd. - Epimedium
China NMPA drug inspection for Chengdu Hexiangtian Pharmaceutical Co., Ltd. published August 16, 2019. Drug: Epimedium. The Sichuan Provincial Drug Administration published a bulletin on August 16, 2019, detailing the outcomes of its 2019 d
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
China NMPA drug inspection for Chengdu Hexiangtian Pharmaceutical Co., Ltd. published August 16, 2019. Drug: Epimedium. The Sichuan Provincial Drug Administration published a bulletin on August 16, 2019, detailing the outcomes of its 2019 d
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox